YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Obstetrics and Gynecology (산부인과학교실)

1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2024Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed high-risk, locally advanced cervical cancer (ENGOT-cx11/ GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trialLANCET
2024Unique immune characteristics and differential anti-PD-1-mediated reinvigoration potential of CD8+ TILs based on BRCA1/2 mutation status in epithelial ovarian cancersJOURNAL FOR IMMUNOTHERAPY OF CANCER
2024Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical CancerNEW ENGLAND JOURNAL OF MEDICINE
2024Effects of subcutaneous drain on wound dehiscence and infection in gynecological midline laparotomy: Secondary analysis of a Korean Gynecologic Oncology Group study (KGOG 4001)EJSO
2024Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E TrialJOURNAL OF CLINICAL ONCOLOGY
2024Efficacy of immune-checkpoint inhibitors combined with cytotoxic chemotherapy in advanced or recurrent endometrial cancer: A systematic review and meta-analysisGYNECOLOGIC ONCOLOGY
2024Ticagrelor, but Not Clopidogrel, Attenuates Hepatic Steatosis in a Model of Metabolic Dysfunction-Associated Steatotic Liver DiseaseNUTRIENTS
2024Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/ GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trialLANCET
2024Clinical practice guidelines for cervical cancer: the Korean Society of Gynecologic Oncology guidelinesJOURNAL OF GYNECOLOGIC ONCOLOGY
2024Durvalumab with or without tremelimumab plus chemotherapy in HRR non-mutated, platinum-resistant ovarian cancer (KGOG 3045): A phase II umbrella trialGYNECOLOGIC ONCOLOGY
2024Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelinesJOURNAL OF GYNECOLOGIC ONCOLOGY
2024Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naive Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort StudyCLINICAL CANCER RESEARCH
2024Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II TrialJOURNAL OF CLINICAL ONCOLOGY
2024Prenatal Diagnosis and Clinical Outcomes of Isolated Mega Cisterna MagnaJOURNAL OF CHILD NEUROLOGY
2024Decision-making process for risk-reducing salpingo-oophorectomy among Korean women with hereditary breast cancer: A grounded theory studyEUROPEAN JOURNAL OF ONCOLOGY NURSING
2024Factors affecting the technical outcome of catheter-directed sclerotherapy for ovarian endometriomasEUROPEAN JOURNAL OF RADIOLOGY
2024Efficacy of large language models and their potential in Obstetrics and Gynecology educationOBSTETRICS & GYNECOLOGY SCIENCE
2024Long-term outcome of transanal irrigation for individuals with spina bifida: a 12-year experience studyTECHNIQUES IN COLOPROCTOLOGY
2024Maternal and Neonatal Outcomes Based on Changes in Glycosylated Hemoglobin Levels During First and Second Trimesters of Pregnancy in Women with Pregestational Diabetes: Multicenter, Retrospective Cohort Study in South KoreaLIFE-BASEL
2024Oral Hormone Replacement Therapy and Uterine Volume in Korean Adolescents with Turner Syndrome: A Retrospective Case-Control StudyJOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY
1234567891011 91

Recent Submissions

  • License
    sherpa_romeo
    sherpa_juliet

OAK

DSpace Software Copyright © 2002-2017 Duraspace Yonsei University Medical Library All right Reserves. / TEL:02-2228-2915 /
YUHSpace는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Links